The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning…
Source: Forbes Markets
